EUVIMEDExplore EUVIMED
CrossrefInfo card

Análisis coste-efectividad de aliskiren en pacientes hipertensos, con diabetes tipo 2 y nefropatía ya tratados de forma óptima con ARA-II y otros fármacos antihipertensivos

M. Brosa, M. de la Figuera, J. Franch, J. Segura, M. Riera, M. Figueras

PharmacoEconomics Spanish Research Articles · 2009

DOI: 10.1007/bf03320855 ↗
AbstractBibliographic details

Abstract

No abstract available.

Knowledge that fits your work.

From a free start through personal literature research to the complete Research Suite.

View plans →

Are all publisher full texts included?

No. Bibliographic records, abstracts and full texts are different content types. Full-text availability depends on the source, open access and your existing licences. An EUVIMED plan does not replace additional publisher rights.

View plans →